171
A First-in-Human Study of BNZ132-1-40
Condition(s):HealthyLast Updated:June 22, 2017Completed
First in Human: 7339 Clinical Trials, Page 18 of 734
Hide Studies Not Open or Pending
172
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
Condition(s):Breast Carcinoma; Colorectal Carcinoma; Lung Carcinoma; Metastatic Malignant Neoplasm in the Breast; Metastatic Malignant Neoplasm in the Colon; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Rectum; Pancreatic CarcinomaLast Updated:February 8, 2023Active, not recruiting
173
HAL-MPE1 First-in-human
Condition(s):Peanut AllergyLast Updated:July 10, 2015Completed
174
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition(s):Advanced Solid Tumor; Metastatic Solid TumorLast Updated:May 25, 2023Not yet recruiting
175
A First-in-Human Study of PRL3-ZUMAB
Condition(s):Advanced Solid TumorsLast Updated:September 3, 2019Unknown status
176
A Phase 1, First-in-human Study of VX-668
Condition(s):Alpha-1 Antitrypsin DeficiencyLast Updated:March 6, 2023Recruiting
177
GEN1047 for Solid Tumors – First in Human (FIH) Trial
Condition(s):Breast Cancer, Breast Neoplasms; Endometrial Cancer, Endometrial Neoplasm; Ovarian Cancer, Ovarian Neoplasms; Squamous Non Small Cell Lung Cancer (NSCLC-SCC)Last Updated:April 21, 2023Recruiting
178
A Phase 1, First-in-human Study of VX-634
Condition(s):Alpha 1-Antitrypsin DeficiencyLast Updated:June 5, 2023Recruiting
179
First-In-Human Study of EOS884448 in Participants With Advanced Cancers.
Condition(s):Advanced CancerLast Updated:June 16, 2022Completed
180
First-in-Human Study With Single and Multiple Doses of TS-161 in Healthy Participants
Condition(s):Healthy VolunteersLast Updated:February 28, 2020Completed